Check Claims Before You Publish

Executive evaluation

Based on the publication record available in major genomics method and resource papers, Guoliang Li has contributed to methods (ChIA-PET) and large resource papers that enabled genomewide promoter–enhancer and chromatin interaction mapping; those publications are high impact and foundational to modern 3D genomics and epigenomics research ChIA-PET method paper Promoter interaction mapping Cell 2012

Evidence base and highest-value outputs

• Primary methods contribution ChIA-PET tool paper (Genome Biology 2010) introduced both wet-lab and computational pipelines for antibody-targeted chromatin interaction mapping; this method remains a core experimental approach for protein‑centric 3D genome studies and is widely referenced in chromatin topology literature ChIA-PET tool paper
• High impact resource papers — promoter‑centered ChIA-PET maps reported in Cell (2012) and later integrative 3D genome studies provided genome-wide datasets that have been reused extensively and cited as foundational maps Promoter interactome Cell 2012
• Complementary work in chromatin and epigenetics — multiple collaborative papers link Li to studies mapping CTCF-mediated topology and methylome dynamics; these additional publications broaden his presence across epigenomic method and resource literature Chromatin connectivity Nature 2013

Quantitative signals of impact

The papers above are highly cited method and resource publications: the Cell 2012 promoter interaction paper (cited >1200 times) and the ChIA-PET tool paper (cited >300 times) indicate sustained community reuse and broad influence in chromatin biology and regulatory genomics Promoter interactome Cell 2012 citations ChIA-PET tool citations

Strengths

• Clear demonstrable impact: author is coauthor on multiple community resources and methods that enabled a field (3D genome mapping) — these papers show high citation counts and broad reuse consistent with major methodological contributions ChIA-PET method evidence
• Work is interdisciplinary: integrates experimental chromatin assays with computational pipelines and large data resources — appropriate for modern genomics.
• Resource orientation: producing community datasets increases reproducibility and downstream reuse (evidence: high citations of resource papers).

Limitations and blindspots

1. Lack of centralized, unambiguous author identifier in public CVs — multiple persons with identical Romanized names exist (OpenAlex lists multiple Guoliang Li profiles); without institutional consistent affiliation metadata a naive bibliometric lookup risks conflating different scientists. This complicates automated metrics aggregation and requires manual disambiguation (note: name disambiguation is a known issue in bibliometrics and can inflate or fragment metrics).
2. Resource papers often have many coauthors; author role varies between first author, method lead, and middle author — precise contribution level for each paper should be checked by reading author contribution statements or correspondence rather than assuming uniform seniority.
3. Method/resource papers provide infrastructure but do not, by themselves, guarantee continuous high-quality hypothesis-driven biology if not followed by mechanistic follow-ups; evaluate both method impact and biological discovery output separately.

How to interpret metrics and identity ambiguity

Public sources (OpenAlex and paper metadata) show that at least one Guoliang Li profile is associated with many high-citation works in 3D genomics and an h-index consistent with a senior researcher; but multiple independent Guoliang Li identities exist and can lead to confusion when aggregating metrics — recommend cross-referencing ORCID, institutional homepage, and author contributions to verify the exact individual behind a claimed metric before using it in hiring/promotion decisions.

Concrete recommendations for evaluators or collaborators

1. Disambiguate identity: require ORCID or institutional email and check author position and contribution statements in target papers.
2. Assess role: when a candidate cites resource papers with many authors, ask for a short description of exact contributions (methods design, pipeline coding, data generation, supervision, analysis, or other).
3. Check reproducibility: if evaluating method work, request code, sample datasets, and pipeline documentation (ChIA-PET paper provided a pipeline; check availability and maintenance of code repositories and raw data accessions).

What would disprove the positive conclusion?

If the high-impact papers attributed to Guoliang Li were shown to be primarily the work of a different person with the same name (identity conflation), or if careful reading of author contributions reveals that Li played a minor transactional role (e.g., technical assistance) rather than leading method development, the assessment of high independent scientific strength would need to be downgraded. Conversely, discovery of a verified ORCID + institutional record tying the high-impact method leadership to this exact individual would confirm the positive evaluation.

Useful links and tools

To continue investigating this author you can run bespoke BGPT queries: